Vorasidenib
(asked on 18th October 2023) - View Source
Question to the Department of Health and Social Care:
To ask His Majesty's Government what discussions they have had with Servier to expand access to vorasidenib for patients that might benefit by including it in the early access to medicines scheme, or by any other means.
This question was answered on 25th October 2023
The Department has had no specific discussions with Servier regarding vorasidenib, and neither has the Medicines and Healthcare Products Regulatory Agency (MHRA). The MHRA has not issued a scientific opinion for Vorasidenib under the early access to medicines scheme but should an application for this be received, the MHRA will consider this accordingly.